Company Profiles

driven by the PitchBook Platform

Cerevast Therapeutics

Description

Developer of tools for the treatment of ischemic stroke and other vascular disorders. The company develops treatment for acute ischemic stroke using a combination therapy, known as sonothrombolyis.

2009

Founded

PRIVATE

Status

11-50

Employees

2ndary - Private

Latest Deal Type

$32.5M

Total Amount Raised

4

Investors

Description

Developer of tools for the treatment of ischemic stroke and other vascular disorders. The company develops treatment for acute ischemic stroke using a combination therapy, known as sonothrombolyis.

Website:

www.cerevast.com

Formerly Known As

WA32609

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Surgical Devices

Primary Office

11601 Willows Road Northeast Suite 100 Redmond, WA 98052United States +1 (425) 748-7529
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Cerevast Therapeutics's full profile, request a free trial.

Cerevast Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Cerevast Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Cerevast Therapeutics Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Genstar CapitalPE/BuyoutMinority000 0000000 0000
Icos CapitalVenture CapitalMinority000 0000000 0000
UT Horizon FundVenture CapitalMinority000 0000000 0000
VerathonCorporationMinority000 0000000 0000
Genstar Capital PE/Buyout
Icos Capital Venture Capital
UT Horizon Fund Venture Capital
Verathon Corporation

Cerevast Therapeutics Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Bradford ZakesChief Executive Officer
John AllemanChief Operating Officer
Patrick BobbittVice President of Clinical Affairs
Anthony AllemanVice President of Operations
Andrew LeoVice President, Regulatory & Quality Affairs
Bradford Zakes Chief Executive Officer
John Alleman Chief Operating Officer
Patrick Bobbitt Vice President of Clinical Affairs
Anthony Alleman Vice President of Operations
Andrew Leo Vice President, Regulatory & Quality Affairs

Cerevast Therapeutics Board Members (4)

NameRepresentingRoleSinceContact
Info
Fredric Moll MDSelfDirector000 0000
Gerald McMorrowVerathonDirector000 0000
Paul ClarkGenstar CapitalChairman000 0000
Yuquan WangSelfBoard Member000 0000
Fredric Moll MD Director Self
Gerald McMorrow Director Verathon
Paul Clark Chairman Genstar Capital
Yuquan Wang Board Member Self
Request full access to PitchBook